← Back to Clinical Trials
Recruiting NCT06796881

NCT06796881 Instrument Assisted Soft Tissue Mobilization Versus Myofascial Release in Patients With Chronic Non¬Specific Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06796881
Status Recruiting
Phase
Sponsor Cairo University
Condition Myofascial Release
Study Type INTERVENTIONAL
Enrollment 66 participants
Start Date 2025-01-23
Primary Completion 2025-05-23

Eligibility & Interventions

Sex All sexes
Min Age 25 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Instrument assisted soft tissue mobilizationMyofascial releaseThe conventional exercise program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 66 participants in total. It began in 2025-01-23 with a primary completion date of 2025-05-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was done to compare the effect of instrumental-assisted soft tissue mobilization versus the effect of myofascial release on pain intensity, pressure pain threshold, back function, and back range of motion in patients with chronic nonspecific low back pain.

Eligibility Criteria

Inclusion Criteria: 1. Patients with chronic non-specific low back pain for more than 3 months. 2. Age between 25-45 years. Exclusion Criteria: 1. Patients who have serious spinal pathologies, such as fractures, tumors or inflammatory diseases (such as ankylosing spondylitis) 2. Patients who have nerve root compromise, disk herniation, spondylolisthesis with neurological involvement, or narrowing of spinal canal 3. Pregnant women 4. Cancer patients . 5. Lower limb injuries. 6. Body mass index (BMI) greater than 25.

Contact & Investigator

Central Contact

Dalia salah Ahmed Elshatoury, physical therapist

✉ safsafahmed53@gmail.com

📞 +201550677823

Frequently Asked Questions

Who can join the NCT06796881 clinical trial?

This trial is open to participants of all sexes, aged 25 Years or older, up to 45 Years, studying Myofascial Release. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06796881 currently recruiting?

Yes, NCT06796881 is actively recruiting participants. Contact the research team at safsafahmed53@gmail.com for enrollment information.

Where is the NCT06796881 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06796881 clinical trial?

NCT06796881 is sponsored by Cairo University. The trial plans to enroll 66 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology